Walleye Capital’s Medline MDLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$15.6M Buy
448,937
+440,089
+4,974% +$16.1M 0.01% 929
2026
Q2
$349K Sell
8,848
-396,425
-98% -$16M ﹤0.01% 3050
2026
Q1
$18M Hold
405,273
– – 0.08% 229
2025
Q4
$17M Buy
+405,273
New +$17.1M 0.05% 365

Other funds holding MDLN

Walleye Capital's MDLN Position: Q3 2026 in Review

Walleye Capital increased its Medline (MDLN) stake by 4,974% in Q3 2026, buying an estimated $16.1M and bringing the position to 448,937 shares worth $15.6M. The position accounts for 0.01% of the portfolio, ranked #929.

Walleye Capital first reported a position in MDLN in Q4 2025 and has held it in 4 quarters since. The position peaked at $18M in Q1 2026. 412 funds tracked by Wall St. Rank hold MDLN as of Q3 2026.

  • Walleye Capital held 448,937 shares of Medline worth $15.6M as of Q3 2026.
  • Walleye Capital bought 440,089 Medline shares in Q3 2026, an estimated $16.1M.
  • Medline made up 0.01% of Walleye Capital's portfolio in Q3 2026, its #929 holding.
  • Walleye Capital first reported a position in Medline in Q4 2025 and has held it in 4 quarters since.
  • Walleye Capital's Medline position peaked at $18M in Q1 2026.
  • 412 funds tracked by Wall St. Rank held Medline as of Q3 2026.

Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.